⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Lawrence AntonucciMD

Cardiology · Chester, NJ 7930

NPI: 1083684914

Share:

9

🟢 Low

Risk Flags

Opioid + benzodiazepine co-prescriber

Risk indicators are statistical patterns, not allegations. Learn more

8,883

Total Claims

$1.4M

Drug Cost

865

Beneficiaries

$1,636

Cost/Patient

Risk Score Breakdown 9/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid + benzodiazepine combo+8

Score components are additive. Read full methodology

Peer Comparison vs. 18,720 Cardiology providers

+7%

Cost per patient vs peers

$1,636 vs $1,524 avg

-7%

Brand preference vs peers

12.6% vs 13.7% avg

⚠️ Opioid + Benzodiazepine Co-Prescriber

This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.

🔎 Data Overview

⚠️

This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

0.3%

Opioid Rate

26

Opioid Claims

$129

Opioid Cost

Long-Acting Rate

Brand vs Generic

87% generic

Brand: 1,118 claims · $1.2M

Generic: 7,720 claims · $226K

Top Prescribed Drugs

Drug (Generic)ClaimsCost
Empagliflozin138$225K
Apixaban135$161K
Semaglutide102$157K
Rivaroxaban43$65K
Dapagliflozin Propanediol40$58K
Semaglutide21$49K
Dulaglutide22$47K
Evolocumab34$36K
Tirzepatide25$32K
Rosuvastatin Calcium1,443$28K
Dronedarone Hcl13$26K
Icosapent Ethyl29$25K
Empagliflozin/Linagliptin14$25K
Sacubitril/Valsartan33$24K
Alirocumab33$24K

Prescribing Profile

97

Unique Drugs

$565K

IRA Negotiated Drugs

$285K

GLP-1 Drugs

9.0

Anomaly Score

Patient Profile

77

Avg Age

52%

Female

1.00

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data